Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Transient neonatal myasthenia gravis: refining risk estimate for infants born to women with myasthenia gravis

Journal of Perinatology volume 41, pages 2279–2283 (2021)Cite this article

Subjects

Abstract

Objective

Transient neonatal myasthenia gravis (TNMG) can render a neonate vulnerable to catastrophic respiratory depression. Our aim was to describe the clinical manifestations of TNMG, and to determine when the myasthenic signs become apparent in TNMG.

Methods

We reviewed our own experience of infants who underwent routine inpatient monitoring for TNMG and combined our local data with observations from previous studies.

Results

Only three case series (n = 110) reported both the type and timing of onset of myasthenic signs. Adding local data (n = 37) yielded 147 infants born to women with MG. Fifteen infants (10%) developed signs of TNMG with onset being 1.5 ± 2.6 days (mean ± 3SD) after birth. Feeding difficulties and low tone were the commonest presenting signs, and only 1 of the 147 infants needed intubation for hypoventilation.

Conclusions

TNMG signs were mostly not life-threatening. We suggest only 4 days of routine postnatal observation for infants born to women with MG.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Sarnet BA. Neuromuscular disorders. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007. p. 2554–7.

  2. Hassoun M, Turjuman UE, Chokr I, Fakhoury H. Myasthenia gravis in the neonate. NeoReviews. 2010;11:e200–5.

    Article  Google Scholar 

  3. Téllez-Zenteno JF, Hernández-Ronquillo L, Salinas V, Estanol B, da Silva O. Myasthenia gravis and pregnancy: clinical implications and neonatal outcome. BMC Musculoskelet Disord. 2004;5:42.

    Article  Google Scholar 

  4. Toyka KV, Gold R. Treatment of myasthenia gravis. Schweiz Arch Neurol Psychiatr. 2007;158:309–21.

    Article  Google Scholar 

  5. Ducci RD, Lorenzoni PJ, Kay CSK, Werneck LC, Scola RH. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord. 2017;27:352–7.

    Article  Google Scholar 

  6. Jovandaric MZ, Despotovic DJ, Jesic MM, Jesic MD. Neonatal outcome in pregnancies with autoimmune myasthenia gravis. Fetal Pediatr Pathol. 2016;35:167–72.

    Article  CAS  Google Scholar 

  7. Niks EH, Verrips A, Semmekrot BA, Prick MJ, Vincent A, van Tol MJ, et al. A transient neonatal myasthenic syndrome with anti-MuSK antibodies. Neurology. 2008;70:1215–6.

    Article  CAS  Google Scholar 

  8. Norwood F, Dhanjal M, Hill M, James N, Jungbluth H, Kyle P, et al. Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry. 2014;85:538–43.

    Article  Google Scholar 

  9. Hanauer DA, Mei Q, Law J, Khanna R, Zheng K. Supporting information retrieval from electronic health records: a report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inf. 2015;55:290–300.

    Article  Google Scholar 

  10. Creasy RK, Resnik R, Greene MF, Iams JD, Lockwood CJ. Maternal fetal medicine: principles and practice. 7th ed. Philadelphia, PA; Elsevier Saunders. 2014. Ch 52, p. 1108–9.

  11. Namba T, Brown SB, Grob D. Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics. 1970;45:488–504.

    CAS  PubMed  Google Scholar 

  12. Braga AC, Pinto C, Santos E, Braga J. Myasthenia gravis in pregnancy: experience of a portuguese center. Muscle Nerve. 2016;54:715–20.

    Article  CAS  Google Scholar 

  13. Townsel C, Keller R, Johnson K, Hussain N, Campbell WA. Seronegative maternal ocular myasthenia gravis and delayed transient neonatal myasthenia gravis. AJP Rep. 2016;6:e133–6.

    Article  Google Scholar 

  14. Lee JY, Min JH, Han SH, Han J. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis. Neuromuscul Disord. 2017;27:655–7.

    Article  Google Scholar 

  15. O’carroll P, Bertorini TE, Jacob G, Mitchell CW, Graff J. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis. J Clin Neuromuscul Dis. 2009;11:69–71.

    Article  Google Scholar 

  16. Béhin A, Mayer M, Kassis-Makhoul B, Jugie M, Espil-Taris C, Ferrer X, et al. Severe neonatal myasthenia due to maternal anti-MuSK antibodies. Neuromuscul Disord. 2008;18:443–6.

    Article  Google Scholar 

Download references

Acknowledgements

Rachael A. Pace from the Department of Pediatrics at the University of Michigan helped with Electronic Medical Record Search Engine to identify the study population.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Neonatal-Perinatal Medicine, University of Michigan Health System, Ann Arbor, MI, USA

    Paramjeet K. Kochhar, Robert E. Schumacher & Subrata Sarkar

Authors
  1. Paramjeet K. Kochhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Subrata Sarkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SS developed the study concept and design, and analyzed the data. He also collected data and critically revised and approved the final manuscript. PK collected data and she received input from the other authors while writing the manuscript. RES provided critical input into the design, and approved the final manuscript.

Corresponding author

Correspondence to Subrata Sarkar.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kochhar, P.K., Schumacher, R.E. & Sarkar, S. Transient neonatal myasthenia gravis: refining risk estimate for infants born to women with myasthenia gravis. J Perinatol 41, 2279–2283 (2021). https://doi.org/10.1038/s41372-021-00970-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-021-00970-6

This article is cited by

Search

Advanced search

Quick links